Scarica l'app Stockscreener
0.00
100.00%
-4.58
Panoramica
Notizia
Cronologia dei prezzi
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$4.58
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$8.94M
Reddito:
$5.27M
Utile/perdita netta:
$-7.98M
Rapporto P/E:
0.00
EPS:
-5.9517
Flusso di cassa netto:
$-7.04M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$4.73
Neurometrix Inc Stock (NURO) Company Profile
Nome
Neurometrix Inc
Settore
Industria
Telefono
(781) 890-9989
Indirizzo
1000 WINTER STREET, WALTHAM
Confronta NURO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NURO
Neurometrix Inc
|
0.00 | 8.94M | 5.27M | -7.98M | -7.04M | -5.9517 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Neurometrix Inc Stock (NURO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2017-10-20 | Reiterato | H.C. Wainwright | Buy |
| 2016-06-28 | Iniziato | Rodman & Renshaw | Buy |
| 2015-09-11 | Iniziato | Maxim Group | Buy |
| 2012-02-27 | Iniziato | Dawson James | Buy |
Neurometrix Inc Borsa (NURO) Ultime notizie
NeuroMetrix Appoints Head of Consumer Health - Medical Product Outsourcing
electroCore Announces Second Quarter 2025 Financial Results - GlobeNewswire
Electrical Stimulation Blood Pressure Treatment Devices - openPR.com
Internet-of-Medical-Things Market Set for Strong Growth Outlook: LifeFuels, Medtronic, NeuroMetrix - newstrail.com
NeuroMetrix (NASDAQ:NURO) Stock Passes Above 200 Day Moving Average – What’s Next? - Defense World
NeuroMetrix (NASDAQ:NURO) Stock Price Passes Above 200-Day Moving Average – Here’s Why - Defense World
Non-Invasive Pain Management Devices Market Detailed in New - openPR.com
NeuroMetrix (NASDAQ:NURO) Share Price Passes Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
NeuroMetrix Releases Q2 Results - Medical Product Outsourcing
NeuroMetrix (NASDAQ:NURO) Earns Sell Rating from Analysts at StockNews.com - Defense World
Tactile Systems Technology (NASDAQ:TCMD) vs. NeuroMetrix (NASDAQ:NURO) Financial Comparison - Defense World
Investor Network: NeuroMetrix, Inc. to Host Earnings Call - ACCESS Newswire
ElectroCore anticipates $30M 2025 revenue amid product line expansion - MSN
Renaissance Technologies LLC Purchases New Shares in NeuroMetrix, Inc. (NASDAQ:NURO) - Defense World
electroCore, Inc. (NASDAQ:ECOR) Q1 2025 Earnings Call Transcript - Insider Monkey
electroCore Announces First Quarter 2025 Financial Results - GlobeNewswire
StockNews.com Initiates Coverage on NeuroMetrix (NASDAQ:NURO) - Defense World
electroCore completes acquisition of neurotechnology solution provider NeuroMetrix - Yahoo
NeuroMetrix (NASDAQ:NURO) and Daxor (NASDAQ:DXR) Head-To-Head Comparison - Defense World
ElectroCore’s Merger with NeuroMetrix: A Strategic Gamble with Chronic Pain - AInvest
electroCore Acquires NeuroMetrix, Expands Pain Management Portfolio By Investing.com - Investing.com Nigeria
NeuroMetrix finalizes acquisition by electroCore - Investing.com Nigeria
NeuroMetrix finalizes acquisition by electroCore By Investing.com - Investing.com South Africa
ElectroCore Completes Merger With NeuroMetrix - marketscreener.com
ElectroCore completes acquisition of NeuroMetrix - MassDevice
electroCore Completes Acquisition of NeuroMetrix - Medical Product Outsourcing
Electrocore Completes Acquisition Of Neurometrix - marketscreener.com
Electrocore Completes Merger with NeuroMetrix - TipRanks
electroCore Acquires NeuroMetrix, Expands Pain Management Portfolio - Investing.com Australia
ECOR Completes Merger with NeuroMetrix to Bolster Health Solutio - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies | ECOR Stock News - GuruFocus
ECOR Completes Merger with NeuroMetrix to Bolster Health Solutions | ECOR Stock News - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, ... - Bluefield Daily Telegraph
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies - GlobeNewswire
electroCore's $4.49/Share NeuroMetrix Buyout Expands Chronic Pain Treatment Portfolio - Stock Titan
NeuroMetrix (NASDAQ:NURO) Stock Price Passes Above 200-Day Moving Average – Time to Sell? - Defense World
NeuroMetrix (NASDAQ:NURO) Now Covered by Analysts at StockNews.com - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
NeuroMetrix (NASDAQ:NURO) Now Covered by StockNews.com - Defense World
StockNews.com Begins Coverage on NeuroMetrix (NASDAQ:NURO) - Defense World
NeuroMetrix (NASDAQ:NURO) vs. Fractyl Health (NASDAQ:GUTS) Head-To-Head Survey - Defense World
NeuroMetrix (NASDAQ:NURO) Coverage Initiated at StockNews.com - Defense World
NeuroMetrix, Inc. SEC 10-K Report - TradingView
NeuroMetrix (NASDAQ:NURO) Stock Passes Above 200-Day Moving Average – Here’s What Happened - Defense World
NeuroMetrix shareholders approve merger with electroCore By Investing.com - Investing.com Australia
NeuroMetrix shareholders approve merger with electroCore - Investing.com
Diabetic Neuropathic Pain Analysis Report 2025: Global - GlobeNewswire
Neurometrix Inc Azioni (NURO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.89%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):